Literature DB >> 7067357

Buerger's disease (thromboangiitis obliterans): an analysis of the arteriograms of 119 cases.

S Suzuki, H Mine, I Umehara, T Yoshida, Y Okada.   

Abstract

One hundred and forty-four lower extremity arteriograms of 119 patients with Buerger's disease have been analysed. The 'corkscrew' appearance of collateral circulation was seen in 27.1% of 144 limbs affected by thromboangiitis obliterans, but in only 3.2% of 63 limbs affected by arteriosclerosis obliterans. We believe that the corkscrew vessel is highly characteristic of Buerger's disease and represents dilated vasa vasorum of the occluded main artery. The appearance of corkscrew vessels extending from the arterial occlusion sites to the periphery of the feet without opacification of the main pedal arteries indicated a poor prognosis.

Entities:  

Mesh:

Year:  1982        PMID: 7067357     DOI: 10.1016/s0009-9260(82)80068-8

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  5 in total

Review 1.  Thromboangiitis obliterans. An update on Buerger's disease.

Authors:  A Szuba; J P Cooke
Journal:  West J Med       Date:  1998-04

2.  Thromoboagiitis Obliterans (TAO).

Authors:  Ui-Jun Park; Dong-Ik Kim
Journal:  Int J Stem Cells       Date:  2010-05       Impact factor: 2.500

3.  Buerger's Disease (Thromboangiitis Obliterans)- Management by Ilizarov's Technique of Horizontal Distraction. A Retrospective Study of 60 Cases.

Authors:  Jagdish Jashwantlal Patwa; Ajay Krishnan
Journal:  Indian J Surg       Date:  2010-12-14       Impact factor: 0.656

4.  [Therapy of peripheral vessel stenosis and occlusion in patients with thromboangiitis obliterans].

Authors:  T A Sandner; C Degenhart; J Becker-Lienau; M F Reiser; M Treitl
Journal:  Radiologe       Date:  2010-10       Impact factor: 0.635

5.  Thoracoscopic dorsal sympathectomy for upper limb Buerger's disease.

Authors:  Reena Kothari; Dhananjaya Sharma; Dileep Singh Thakur; Vinod Kumar; Uday Somashekar
Journal:  JSLS       Date:  2014 Apr-Jun       Impact factor: 2.172

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.